EGFR and neoplasm: Moreover, abnormal fucosylation in tumors is often linked to the activation of receptors like EGFR and TGF-βR, which affect the functions of integrins, selectins, and apoptotic signaling pathways, ultimately impacting tumor growth, invasion, cell death, and metastasis.